NEW YORK, NY / ACCESS Newswire / August 10, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Paramount Group Inc ("Paramount" or "the Company") (NYSE:PGRE). Investors who purchased Paramount securities prior to 2022, and continue to hold to the present, are encouraged to obtain additional information and […]

NEW YORK CITY, NY / ACCESS Newswire / August 10, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Fortrea Holdings, Inc. ("Fortrea" or "the Company") (NASDAQ:FTRE). Investors who purchased Fortrea securities prior to July 3, 2023, and continue to hold to the present, are encouraged to obtain

NEW YORK, NY / ACCESS Newswire / August 10, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Equinix, Inc. ("Equinix" or "the Company") (NASDAQ:EQIX). Investors who purchased Equinix securities prior to May 3, 2019, and continue to hold to the present, are encouraged to obtain additional information

NEW YORK, NY / ACCESS Newswire / August 10, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of The Trade Desk, Inc. ("Trade Desk" or "the Company") (NASDAQ:TTD). Investors who purchased Trade Desk securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s

NEW YORK, NY / ACCESS Newswire / August 10, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of BellRing Brands, Inc. ("BellRing Brands, Inc.") (NYSE:BRBR) concerning possible violations of federal securities laws. On May 6, 2025, BellRing Brands during its second quarter of 2025 earnings call revealed that certain customers

NEW YORK, NY / ACCESS Newswire / August 10, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Abacus Global Management, Inc. ("Abacus" or the "Company") (NASDAQ:ABL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Abacus and certain of its officers and/or

NEW YORK, NY / ACCESS Newswire / August 10, 2025 / If you suffered a loss on your Flywire Corporation (NASDAQ:FLYW) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/flywire-corporation-lawsuit-submission-form?prid=160655&wire=1&utm_campaign=19 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

NEW YORK, NY / ACCESS Newswire / August 10, 2025 / If you suffered a loss on your Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/rocket-pharmaceuticals-inc-lawsuit-submission-form?prid=160657&wire=1&utm_campaign=24 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

NEW YORK, NY / ACCESS Newswire / August 10, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Jasper Therapeutics, Inc. ("Jasper" or the "Company") (NASDAQ:JSPR). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Jasper and certain of its officers and/or directors

NEW YORK, NY / ACCESS Newswire / August 10, 2025 / If you suffered a loss on your Lineage, Inc. (NASDAQ:LINE) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/lineage-inc-lawsuit-submission-form?prid=160658&wire=1&utm_campaign=26 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call